Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Repurposing metformin as a potential anticancer agent using in silico technique. | Daru | 2024 | 38922530 | PubTator, text mining | PubMed |
| Surface functionalization of hydroxyapatite nanoparticles for biomedical applications. | J Mater Chem B | 2024 | 38919049 | PubTator, text mining | PubMed |
| Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3/FABP5 mediated fatty acid oxidation. | Int J Biol Sci | 2024 | 38904015 | PubTator, text mining | PubMed |
| From waste to wealth: iron oxide doped hydroxyapatite-based biosensor for the colorimetric detection of ascorbic acid. | RSC Adv | 2024 | 38895531 | PubTator, text mining | PubMed |
| Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. | Blood Adv | 2024 | 38885484 | PubTator, text mining | PubMed |
| Population structure of Taenioides sp. (Gobiiformes, Gobiidae) reveals their invasion history to inland waters of China based on mitochondrial DNA control region. | Zookeys | 2024 | 38855790 | PubTator, text mining | PubMed |
| A Novel Strategy for Fabrication of Polyamide 66/Nanohydroxyapatite Composite Bone Repair Scaffolds by Low-Temperature Three-Dimensional Printing. | ACS Biomater Sci Eng | 2024 | 38752228 | PubTator, text mining | PubMed |
| Different solvents and organic modifiers for the control of crystallographic parameters in nano-crystallite hydroxyapatite for amplification of photocatalytic activity. | Nanoscale Adv | 2024 | 38752133 | PubTator, text mining | PubMed |
| Postoperative subphenotypes modified the hepatoma arterial-embolization prognostic score: A novel smHAP-II nomogram. | J Cancer | 2024 | 38706898 | PubTator, text mining | PubMed |
| Partnership building for scale-up in the Veteran Sponsorship Initiative: Strategies for harnessing collaboration to accelerate impact in suicide prevention. | Health Serv Res | 2024 | 38689547 | PubTator, text mining | PubMed |
| A comprehensive review on the biomedical frontiers of nanowire applications. | Heliyon | 2024 | 38628721 | PubTator, text mining | PubMed |
| A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma. | BMC Med Genomics | 2024 | 38627714 | PubTator, text mining | PubMed |
| Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib. | BMC Gastroenterol | 2024 | 38589828 | PubTator, text mining | PubMed |
| Reticulon 3 deficiency ameliorates post-myocardial infarction heart failure by alleviating mitochondrial dysfunction and inflammation. | MedComm (2020) | 2024 | 38420163 | PubTator, text mining | PubMed |
| Silk Fibroin Materials: Biomedical Applications and Perspectives. | Bioengineering (Basel) | 2024 | 38391652 | PubTator, text mining | PubMed |
| Reticulon 3 regulates sphingosine-1-phosphate synthesis in endothelial cells to control blood pressure. | MedComm (2020) | 2024 | 38352050 | PubTator, text mining | PubMed |
| RTN3 deficiency exacerbates cisplatin-induced acute kidney injury through the disruption of mitochondrial stability. | Mitochondrion | 2024 | 38336146 | PubTator, text mining | PubMed |
| Hydroxyapatite and its composite in heavy metal decontamination: Adsorption mechanisms, challenges, and future perspective. | Chemosphere | 2024 | 38331264 | PubTator, text mining | PubMed |
| Correction to: Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK-IDH2 pathway. | MedComm (2020) | 2024 | 38318159 | PubTator, text mining | PubMed |
| Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. | Mol Cancer | 2024 | 38262996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=5